Literature DB >> 29519822

Full-Genome Sequence of Infectious Laryngotracheitis Virus (Gallid Alphaherpesvirus 1) Strain VFAR-043, Isolated in Peru.

Sandra Morales Ruiz1, Jorge Bendezu Eguis2, Ricardo Montesinos2, Luis Tataje-Lavanda3, Manolo Fernández-Díaz2,3.   

Abstract

We report here the first genome sequence of infectious laryngotracheitis virus isolated in Peru from tracheal tissues of layer chickens. The genome showed 99.98% identity to the J2 strain genome sequence. Single nucleotide polymorphisms were detected in five gene-coding sequences related to vaccine development, virus attachment, and viral immune evasion.
Copyright © 2018 Morales Ruiz et al.

Entities:  

Year:  2018        PMID: 29519822      PMCID: PMC5843735          DOI: 10.1128/genomeA.00078-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Infectious laryngotracheitis is an avian respiratory disease which is caused by infectious laryngotracheitis virus (ILTV), and clinical signs vary from coughing, conjunctivitis, and gasping to expectoration of bloody mucus and death (1). Whereas genomic database analysis allowed the identification of an ILTV field strain in Australia as a causative agent of outbreaks as a result of recombination between attenuated vaccine viruses (2), genomic sequence data from viral outbreaks in South America are still unavailable. ILTV was reported for the first time in Peru by the Servicio Nacional de Sanidad Animal (SENASA) in 2008 (3). ILTV in Peruvian poultry has been associated with a 16% decrease in egg production, an 18% increase in layer chicken mortality (3), and a 27.3% decrease in productive efficiency in broilers (4). In December 2014, an ILT outbreak occurred at a farm in Chincha Alta, Ica, Peru. An ILTV field strain named VFAR-043 was isolated from tracheal tissues and propagated onto the chorioallantoic membrane (CAM) of specific-pathogen-free eggs (5). This animal study was approved by the institutional ethics committee of the Universidad Peruana Cayetano Heredia, Lima, Peru (SIDISI 65330). Total genomic DNA was extracted from the suspension of the inoculated CAMs using a phenol-chloroform method (6). Whole-genome sequencing was performed by Macrogen, Inc. (South Korea), using a HiSeq 2000 platform. The reads were assembled de novo using NextGene (7), with a coverage of 87×. The open reading frames (ORFs) were analyzed and annotated using SnapGene (GSL Biotech LLC) and Artemis (8). BLAST (9) was performed to determine gene identity. The genome of VFAR-043 was 152,701 bp long. The genome was composed of a unique long (UL) sequence and a unique short (US) sequence, which were 113,917 bp and 13,125 bp, respectively. The US sequence was flanked by inverted internal repeat (IR) and terminal repeat (TR) sequences of 12,829 bp and 12,830 bp, respectively. The G+C content was 48.06%, and the genome encodes 79 predicted ORFs. VFAR-043 showed 99.98% identity to the J2 strain, which was reported as a possible parental virus of American strains (10). A 98.85% identity was obtained as a result of alignment against the genome sequence of strain 4787/80 isolated from Italy, which has been associated with an attenuated vaccine revertant introduced into Europe from America (11). Moreover, VFAR-043 shared 99.47% identity with the Australian reference vaccine SA2 strain. We found nonsynonymous single nucleotide polymorphisms (nsSNPs) in 5 gene-coding sequences (CDS) of VFAR-043 in comparison to the SA2 strain. We detected 4 nsSNPs in glycoprotein B (gB) (UL27), a protein which is associated with viral attachment to cells (11); 2 nsSNPs for gE (US8), a protein which has a role in the cell-to-cell spread of ILTV (12); 6 nsSNPs for gD (US6), a protein which is a receptor for ILTV binding and entry to susceptible cells (11); 8 nsSNPs in gG (US4), which is a chemokine-binding protein (13); and 10 nsSNPs for gJ (US5), a protein which blocks the apoptotic cascade in host cells (11). To our knowledge, this work presents the first ILTV genome sequence reported in South America; therefore, this study will allow us to clarify ILTV epidemiology in Peru and to contribute to the knowledge of this virus in this region.

Accession number(s).

This full-genome sequence of the VFAR-043 strain has been deposited to GenBank under accession no. MG775218. The version described in this paper is the first version, MG775218.1.
  9 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  A glycoprotein I- and glycoprotein E-deficient mutant of infectious laryngotracheitis virus exhibits impaired cell-to-cell spread in cultured cells.

Authors:  J M Devlin; G F Browning; J R Gilkerson
Journal:  Arch Virol       Date:  2006-02-26       Impact factor: 2.574

3.  Genetic Diversity of Infectious Laryngotracheitis Virus during In Vivo Coinfection Parallels Viral Replication and Arises from Recombination Hot Spots within the Genome.

Authors:  Carlos A Loncoman; Carol A Hartley; Mauricio J C Coppo; Paola K Vaz; Andrés Diaz-Méndez; Glenn F Browning; Maricarmen García; Stephen Spatz; Joanne M Devlin
Journal:  Appl Environ Microbiol       Date:  2017-11-16       Impact factor: 4.792

Review 4.  Molecular biology of avian infectious laryngotracheitis virus.

Authors:  Walter Fuchs; Jutta Veits; Dorothee Helferich; Harald Granzow; Jens P Teifke; Thomas C Mettenleiter
Journal:  Vet Res       Date:  2007-02-13       Impact factor: 3.683

Review 5.  Immune responses to infectious laryngotracheitis virus.

Authors:  Mauricio J C Coppo; Carol A Hartley; Joanne M Devlin
Journal:  Dev Comp Immunol       Date:  2013-04-06       Impact factor: 3.636

6.  Detection of infectious laryngotracheitis virus infected cells with cloned DNA probes.

Authors:  E Nagy
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

7.  Attenuated vaccines can recombine to form virulent field viruses.

Authors:  Sang-Won Lee; Philip F Markham; Mauricio J C Coppo; Alistair R Legione; John F Markham; Amir H Noormohammadi; Glenn F Browning; Nino Ficorilli; Carol A Hartley; Joanne M Devlin
Journal:  Science       Date:  2012-07-13       Impact factor: 47.728

8.  Full Genome Sequence-Based Comparative Study of Wild-Type and Vaccine Strains of Infectious Laryngotracheitis Virus from Italy.

Authors:  Alessandra Piccirillo; Enrico Lavezzo; Giulia Niero; Ana Moreno; Paola Massi; Elisa Franchin; Stefano Toppo; Cristiano Salata; Giorgio Palù
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

9.  Complete genome sequence of the first Chinese virulent infectious laryngotracheitis virus.

Authors:  Congcong Kong; Yan Zhao; Xianlan Cui; Xiaomin Zhang; Hongyu Cui; Mei Xue; Yunfeng Wang
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  9 in total
  2 in total

1.  Glycoprotein G (gG) production profile during infectious laryngotracheitis virus (ILTV) infection.

Authors:  Jorge Bendezu; Sandra Morales Ruiz; Ricardo Montesinos; Ricardo Choque Guevara; Aldo Rojas-Neyra; Katherine Pauyac-Antezana; Manolo Fernández-Díaz
Journal:  PLoS One       Date:  2019-08-21       Impact factor: 3.240

2.  Infectious laryngotracheitis: Etiology, epidemiology, pathobiology, and advances in diagnosis and control - a comprehensive review.

Authors:  Vasudevan Gowthaman; Sachin Kumar; Monika Koul; Urmil Dave; T R Gopala Krishna Murthy; Palanivelu Munuswamy; Ruchi Tiwari; Kumaragurubaran Karthik; Kuldeep Dhama; Izabela Michalak; Sunil K Joshi
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.